CARL – carlsmed, inc. (US:NASDAQ)

News

Carlsmed Reports Q4, FY 2025 revenue above estimate [Seeking Alpha]
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com